Related Experiment Video
Updated: Aug 12, 2026

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells
Published on: August 15, 2012
Binding of human immunodeficiency virus type-1 to follicular dendritic cells in vitro is complement dependent
P Joling1, L J Bakker, J A Van Strijp
1Department of Pathology, University Hospital, Utrecht, The Netherlands.
Insights
Human immunodeficiency virus type 1 (HIV-1) binds to follicular dendritic cells (FDC) in fresh serum. This binding is dependent on complement component C3 and enhanced by antibodies from infected patients.
Area of Science:
- Immunology
- Virology
- Cell Biology
Background:
- Follicular dendritic cells (FDC) play a crucial role in adaptive immunity.
- Understanding how viruses interact with FDC is vital for comprehending viral pathogenesis and immune evasion strategies.
Purpose of the Study:
- To investigate the in vitro binding of human immunodeficiency virus type 1 (HIV-1) to FDC.
- To elucidate the role of serum components, including complement factors and antibodies, in mediating HIV-1 binding to FDC.
Main Methods:
- Flow cytometry and fluorescence microscopy were used to quantify HIV-1 binding to FDC.
- Immunogold electron microscopy provided ultrastructural evidence of viral binding.
- Experiments utilized serum from healthy donors and HIV-1-infected patients, with and without specific complement factors (C3, C5).
Main Results:
- HIV-1 binding to FDC was significantly enhanced in the presence of fresh serum, particularly from HIV-1-infected patients.
- Binding was dependent on complement component C3 but not C5.
- Anti-HIV-1 antibodies enhanced binding but were insufficient to mediate it alone.
- Most bound HIV-1 virions were located extracellularly on FDC, contrasting with intracellular localization on blood mononuclear cells.
Conclusions:
- HIV-1 virions adhere to FDC in vitro via a mechanism dependent on complement component C3.
- Antibodies from HIV-1-infected individuals can enhance this binding process.
Abstract:
The authors studied the binding in vitro of HIV-1 virus particles, conjugated to fluorescein isothiocyanate, to follicular dendritic cells (FDC) isolated from human tonsils. Analysis was done using flow cytometry, fluorescence microscopy, and immunogold electron microscopy. The focus of study was on the effect of serum from various origins, including pooled fresh serum and heated serum from control donors and pooled heated serum from HIV-1-infected patients (containing anti-HIV-1 antibodies). In the presence of heated serum, either from controls or from HIV-1-infected patients, the fluorescence signal in flow cytometry was similar to the background value. In the presence of fresh serum, the signal was substantially increased, and an even higher signal was observed in the presence of fresh serum and serum from HIV-1-infected patients. This high fluorescence signal was also found in the presence of serum depleted of complement factor C5, but not with serum deficient in complement factor C3. The binding of HIV-1 virions to FDC in the presence of fresh serum was confirmed by fluorescence microscopy on cytospot preparations. After quenching of the extracellular fluorescence with trypan blue, the fluorescence was reduced to about 30% of the initial value, indicating that most of bound fluorescent virions were present extracellularly. Similar experiments using blood mononuclear cells showed that fluorescent HIV-1 particles after binding to these cells were present intracellularly. This flow cytometry data was confirmed in immunogold electron microscopy demonstrating that most HIV-1 gag p24 or FITC label was present at the outside of FDC and on adherent virus particles. We conclude that HIV-1 virions adhere to FDC in vitro in a complement component C3-dependent way. Anti-HIV-1 antibodies in serum from HIV-1 infected patients enhance binding but, by itself, are unable to mediate binding.
Related Concept Videos
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...

